Identification of Patients with Malaria – PST04102 Disease Control and Prevention

NTA Level 4 • Semester 1 • PST04102

Identification of Patients with Malaria

Disease Control and Prevention • Source Session/Topic 15
Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability.

Session 15: Identification of Patients with Malaria

Total Session Time: 120 minutes + 2 hours Assignment

Prerequisites

• None

Learning Tasks

By the end of this session studentsare expected to be able to:

• Describe Causes of Malaria,
• Describe Mode of Transmission of Malaria
• Describe Major Signs and Symptoms of Malaria
• Explain Treatment of Malaria
• Explain Prevention and Control of Malaria

Resources Needed

• Flip charts, marker pens, and masking tape
• Black/white board, chalk and whiteboard markers
• Computer and LCD projector
• Handout 15.1; Life cycle of malaria parasite
• Handout 15.2; Treatment of uncomplicated malaria

SESSION OVERVIEW

|Step |Time |Activity/ |Content |

| | |Method | |

|1 |5 minutes |Presentation |Introduction, Learning Tasks |

|2 |5 minutes |Presentation |Cause(s) of Malaria |

|3 |30 minutes |Presentation |Mode of Transmission of Malaria |

|4 |15 minutes |Presentation |Major Signs and Symptoms of Malaria |

| | |Brainstorming | |

|5 |30 minutes |Presentation |Treatment of Malaria |

|6 |20 minutes |Presentation |Prevention and Control of Malaria |

| | |Buzzing | |

|7 |5 minutes |Presentation |Key Points |

|8 |5 minutes |Presentation |Evaluation |

|9 |5 minutes |Presentation |Assignment |

SESSION CONTENTS

STEP 1: Presentation of Session Title and Learning Tasks (5 minutes)

READ or ASK students to read the learning tasks and clarify

ASK students if they have any questions before continuing

STEP 2: Causes of Malaria (5 minutes)

Malaria

• An acute infection of the blood caused by protozoa of genus Plasmodium
• Malaria is the most common disease in the tropical Africa

Causative Agents of Malaria

There are 4 different species of Malaria parasite which infect human

beings:

• Plasmodium falciparum (commonest cause of Malaria in Tanzania)
• Plasmodium Malariae
• Plasmodium vivax
• Plasmodium ovale

STEP 3: Mode of Transmission of Malaria (30 minutes)

• Malaria is transmitted by the female Anopheles mosquito which requires

human blood for the development of eggs.

• The male mosquito does not suck human blood.
• Major Anopheles species of importance in Africa include:

o Anopheles Gambiae -Most important vector in Africa.

o Anopheles Funestus – Breeds in permanent vegetation e.g. swamps.

[pic]

Figure 15.1 Spread of malaria

Life cycle of malaria parasite

• Divided into two phases

o Asexual cycle occurring in human

o Sexual or sporogony cycle occurring in female Anopheles (mosquito)

Life Cycle of Malaria Parasites in Man (Asexual Cycle)

• Sporozoites in the mosquito salivary glands are injected into the host

via the proboscis of the mosquito

• They quickly migrate to the liver
• The hepatic (Liver) stage

o The Sporozoites is taken up by the Kupffer cells of the liver and then

passes through into the hepatocytes or liver cells

o There, it develops into hepatic Schizont, releasing thousands of

Merozoites into the general circulation

• Hypnozoites

o This stage of the parasites only occurs in Plasmodium Ovale and

Plasmodium Vivax

o The Hypnozoites mature unpredictably and releases new Merozoites

responsible for recurrent infections up to 18 months after primary

infection, even though earlier blood stages may have been cured

o Without treatment (specific) using primaquine, it is thought that this

stage may remain in the liver for life

• Erythrocytic or Blood Stage

o The merozoites released from the liver invade individual red blood

cells (RBCs) and then develop within the RBCs from “rings” into blood

schizonts

o The schizonts then rupture the RBCs releasing numerous merozoites

which invade new RBCs

o It is this part of the cycle that causes clinical illness, and then

Length of time for each RBC cycle gives the periodicity of the

symptoms

• Gametocytes

o At unknown stage or time in the RBCs cycle, ‘sexual’ forms develop and

are in turn responsible for the survival and transmission of the

parasite

o Male and female gametocytes circulate for a few weeks and are taken up

by the feeding mosquito

Life Cycle of Malaria Parasites in Mosquito (Sexual Cycle of Malaria

Parasites)

• Sexual reproduction, the male and female gametocytes develop into gametes

and then fuse in the stomach of mosquito to form a zygote

• This develops into a mobile ookinete which immigrates through the wall of

the stomach to form an oocyst

• Oocyst matures and releases sprorozoites
• Sporozoites migrate to the salivary glands ready for delivery with the

mosquito’s next meal

[pic]Refer to handout 15.1: Life Cycle of Malaria Parasite

STEP 4: Major Signs and Symptoms of Malaria (15 minutes)

|Activity: Brainstorming (5 minutes) |

| |

|ASK students to brainstorm on the following question |

| |

|What are the major signs and symptoms of Malaria? |

| |

|ALLOW few students to respond |

| |

|WRITE their responses on the flip chart/ board |

| |

|CLARIFY and SUMMARISE by using the content below |

Signs and symptoms of Malaria

The signs and symptoms of Malaria are non–specific and can mimic

symptoms of systemic viral illnesses or other disease condition. The

occurrence of Malaria signs and symptoms may differ in children and

adults

Signs and symptoms of uncomplicated Malaria

• Fever
• Headache
• Malaise
• Joint pains
• Vomiting /diarrhoea
• Body ache
• Poor appetite
• Body weakness
• Pallor
• Enlarged spleen

Signs and symptoms of Severe Malaria

• Extreme weakness
• Impaired consciousness
• Change of behaviour ( hallucinations, delusions, agitation, and acute

state of confusion)

• Respiratory distress
• Bleeding tendency
• Jaundice
• Circulatory collapse/ shock
• Vomiting everything
• Inability to drink or breastfeed

STEP 5: Treatment of Malaria (30 minutes)

Treatment of Uncomplicated Malaria with First Line Drugs

• Artemether/ Lumefantrine (ALU) an oral fixed combination tablet of 20 mg
Artemether (a derivative of artemisinin) and 120 mg Lumefantrine
• A simple dosage regimen is recommended to improve compliance:

o The first dose should be given as Direct Observation Treatment (DOT)

o The second dose should strictly be given after 8 hours

o Subsequent doses could be given twice daily (morning-evening) until

completion of 6 doses

[pic]Refer to Handout 15.2: Treatment Schedule of uncomplicated Malaria

using ALU

Contra-indications of ALU

• Hypersensitivity to either Artemether or Lumefantrine
• First trimester in Pregnancy

Side Effects of ALU

• Sleep disorders
• Headache
• Dizziness
• Nausea
• Anorexia
• Abdominal pain
• Itching and skin rash
• Joint and muscle pain
• Palpitation

Other Artimesinin Combined Therapy (ACT) options Treatment of Uncomplicated

Malaria

• Recommended ACTs options for the treatment of uncomplicated Malaria are

those with minimum 3-day course which include:

o Dihydroartemesinin-Piperaquine (DPQ) –Oral

o Artesunate-Amodiaquine-oral

o Artesunate-Mefloquine-oral

Treatment of Severe Malaria

• The medicine of choice for treatment of severe Malaria is injectable

Artesunate

• Injectable Quinine is to be used when Artesunate is contraindicated such

as allergy, medicine interaction, non-response or when it is not

available.

Artesunate Injection

• Give injectable antiMalarial for minimum of 24 hours even if the patient

can tolerate oral medication earlier before 24 hours, and thereafter,

complete treatment by giving a complete course of Artemether-Lumefantrine

• Available formulations are: 30mg, 60mg and 120mg of Artesunate for

injection.

The recommended formulation for public sector is 60mg

Injectable Quinine

• Injectable Quinine is the alternative treatment for severe Malaria.

Formulated as Injection 600mg in 2mls

• Indications

o Acceptable alternative choice for treatment of severe Malaria

o Medicine of choice for treatment of severe Malaria in first trimester

of pregnancy

• Contraindications

o Hypersensitivity to quinine

o Optic neuritis

o Myasthenia gravis

• Adverse effects

o Cinconism (Tinnitus, Vertigo and Dizziness)

o Hypotension

o Hypoglycaemia

o Injection site abscess

• Administration
o Quinine dihydrochloride injection 10mg/kg is given by intravenous

infusion Where

▪ Diluted in 10 ml/kg. body weight of 5% dextrose or dextrose –

saline

▪ Infused over 4 hours and repeated every 8 hours.
▪ Nine doses then continue with ALU

STEP 6: Prevention and Control of Malaria (20 minutes)

|Activity: Buzzing (10 minutes) |

| |

|ASK students to pair up and buzz on the following question for 2 |

|minutes |

| |

|What are the methods for preventing and controlling Malaria? |

| |

|ALLOW few pairs to respond and let other pairs to add on points not |

|mentioned |

| |

|WRITE their response on the flip chart/board |

| |

|CLARIFY and SUMMARIZE by using the content below |

• Reducing the host reservoir

o This is done by prompt diagnosis and appropriate treatment of infected

individuals

o Controlling the vector population by:

▪ Killing adult mosquito with insecticides
▪ Killing larvae with larvicides
• Prevention of breeding by environmental sanitation
• Using pre intermittent preventive treatment in pregnancy
• Use of insecticides treated nets (ITN)
• Use of chemoprophylaxis for example Mefloquine, Proguanil Hydrochloride

and Doxycycline

STEP 6: Key Points (5 minutes)

• Malaria is an acute infection of the blood with plasmodia,

characterized by fever, joint pains headache and resulting in anaemia

because of haemolysis

• Route of transmission is mostly by the bite of infective female

Anopheles mosquito

• ALu-ACT based combinations are recommended for first line treatment of

Malaria.

• Prevention and control of sources of Malaria is important in reducing

Malaria

STEP 7: Evaluation (5 minutes)

• What are the species that cause Malaria?
• What is the mode of transmission of Malaria?
• What are major signs and symptoms of Malaria?
• What is treatment of Malaria?
• What are methods prevention and control of Malaria?

STEP 8: Assignment (5 minutes)

|Activity: Take Home Assignment (5 minutes) |

| |

|DIVIDE students in groups or individuals |

| |

|ASK the students to work on the following Assignment |

|Prepare a presentation to be delivered to the class indicating |

|prevention and control methods of Malaria you use in your house hold |

| |

|ALLOCATE time for students to do the assignments and submit |

| |

|REFER students to recommended reference |

References

Cook, G. & Zumla, A. (2003). Manson’s Tropical Diseases. (21st ed.).

London: Saunders Ltd

Denyer, S. P., Hodges, N. A., & Gorman, S. P (2011) (Ed).Hugo & Russell’s

Pharmaceutical Microbiology (8thed). Oxford: Willey-Blackwell publishing

Eshuis, J.& Manschot, P. (1992).Communicable diseases,(1st ed). Nairobi:

AMREF

GoT (2004): National Infection Prevention and Control (IPC) Guidelines for

Healthcare Workers. Dar es Salaam: MOHSW

GoT (2013) National Guidelines for Diagnosis and Treatment of Malaria. Dar

es salaam: MOHSW

GoT (2013) Standard Treatment Guidelines & National Essential Medicines

List (4thed).

Dar es Salaam: MOHSW

Nordberg, E. (1999): Communicable Diseases, A Manual for Health Workers in

Sub-Saharan Africa, Nairobi: AMREF

Nordberg, E., Kingondu, T., & Mugambi, E., et al. (2008) Communicable

Diseases. (4thed.). Nairobi: AMREF

Handout 15.1 Life Cycle of Malaria Parasite

[pic]

[pic]Handout 15.2 Dosage Schedule for Artemether-Lumefantrine

| |

|Kg | |Day 1 |Day 2 |Day 3 |

| |

Source: National Guidelines for Malaria Diagnosis and Treatment, 2013

PDF / OFFLINE NOTES

Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP

WhatsApp: 255620339260
banner
Scroll to Top